- Report
- July 2024
- 93 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- July 2024
- 156 Pages
Global
From €3307EUR$3,613USD£2,810GBP
€3890EUR$4,250USD£3,306GBP
- Report
- July 2024
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- July 2024
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- January 2023
- 280 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- July 2022
- 180 Pages
Global
From €2364EUR$2,583USD£2,010GBP
€3378EUR$3,690USD£2,871GBP
- Book
- July 2023
- 304 Pages
- Book
- July 2022
- 560 Pages
United States
- Book
- June 2021
- 592 Pages
- Book
- December 2018
- 416 Pages
- Book
- April 2015
- 352 Pages
- Book
- May 2010
- 448 Pages
- Book
- February 2010
- 340 Pages
Global
- Book
- January 2025
- 464 Pages
- Book
- July 2025
- 604 Pages

The Pathogen market is a subset of the Infectious Disease Testing market, which focuses on the detection and identification of pathogens. Pathogens are microorganisms that cause disease, such as bacteria, viruses, fungi, and parasites. Pathogen testing is used to diagnose and monitor infectious diseases, as well as to detect the presence of pathogens in food, water, and other environmental samples. Pathogen testing is also used to detect the presence of antibiotic-resistant bacteria, which can help inform treatment decisions.
Pathogen testing is a rapidly growing market, driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for more accurate and rapid testing methods. The market is expected to continue to grow in the coming years, driven by advances in technology and the increasing demand for rapid and accurate testing.
Some companies in the Pathogen market include Cepheid, Hologic, Becton Dickinson, Roche, Abbott, and Qiagen. Show Less Read more